Tianjin Ringpu Bio-Technology Co.,Ltd. reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 1,587.16 million compared to CNY 1,476.76 million a year ago. Revenue was CNY 1,587.16 million compared to CNY 1,476.76 million a year ago.

Net income was CNY 273.7 million compared to CNY 233.02 million a year ago. Basic earnings per share from continuing operations was CNY 0.59 compared to CNY 0.5036 a year ago. Diluted earnings per share from continuing operations was CNY 0.59 compared to CNY 0.5036 a year ago.